Indeed, low levels of CD81 correlate with HCC metastasis and tumor proliferation (Inoue et al., 2001; Mazzocca et al., 2008) and expression of CD81 suppresses hepatocellular carcinoma development (Li et al., 2020). Here, CD81 is linked to hepatocellular carcinoma.